GEISTWERT Rechtsanwälte Lawyers Avvocati

UPC_CFI_620/2025, UPC_CFI_1509/2025, UPC_CFI_1511/2025

GlaxoSmithKline Biologicals SA v. Pfizer et al.

Datum
2026-02-25
Kammer
The Hague (NL) Local Division
Verfahrensart
Infringement Action
Sprache
EN

Metadaten

Fall-IDUPC_CFI_620-2025-UPC_CFI_1509-2025-UPC_CFI_1511-2025-9ff9b86c19a4
Aktenzeichen
RegisterzeichenUPC_CFI_620/2025, UPC_CFI_1509/2025, UPC_CFI_1511/2025
Entscheidungsreferenz
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 5

1 The Hague Local Division UPC_CFI_620/2025 UPC_CFI_1509/2025 UPC_CFI_1511/2025 Procedural Order of the Court of First Instance of the Unified Patent Court delivered on 25/02/2026 R.9 CLAIMANT GlaxoSmithKline Biologicals SA,Rue de l’Institut 89, 1330 Rixensart, Belgium Represented by Carlos Andres van Staveren, Tjibbe Douma, Nicole Jadeja (Bird & Bird) DEFENDANTS 1. C.P. Pharmaceuticals International C.V ., Rivium Westlaan 142, 2909LD Capelle aan den Ijssel, the Netherlands 2. Pfizer Export B.V., Rivium Westlaan 142, 2909 LD Capelle aan den IJssel, the Netherlands 3. Pfizer B.V., Rivium Westlaan 142, 2909 LD Capelle aan den IJssel, the Netherlands 4. Pfizer Manufacturing Belgium N.V., Rijksweg 12, 2870 Puurs-Sint-Amands, Belgium 5. Pfizer Service Company B.V./S.r.l., Hoge Wei 10, 1930 Zave ...